Clinical Trial Update: Minimally Invasive Imagery With Indocyanine Green [Phase 1]

View source ↗

Summary

A Phase 1 trial investigating minimally invasive imaging with indocyanine green for neoplasms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: University of Pennsylvania | Conditions: Neoplasms | Phase 1 | Status: COMPLETED